Business Development Dermatology Development 
XTalks
APRIL 26, 2023
He began his career in business development and commercial strategy roles at Genentech. Poster Presentation, Innovations in Dermatology Conference, Las Vegas, NV, November 3-5, 2022. Dermatology. Dermatology. Hear more about the innovative technology and application of DermaSensor in this episode. 2004;208:27-31.
The Pharma Data
NOVEMBER 8, 2020
Almirall strengthens its leadership in medical dermatology by reinforcing its management team in France and obtaining reimbursement in France of Ilumetri ® (tildrakizumab) for treating moderate to severe chronic plaque psoriasis in adults. We have done this by both internal talent development as well as by external hires.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 9, 2021
After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more.
The Pharma Data
JANUARY 3, 2021
Magnus Kjellberg, CEO and co-president, and Gennaro Falanga, co-president, stated: “Over the past few years, we have built up a science-driven, global business spanning 70 worldwide countries dedicated to healthy, vibrant pets for life. We have a particular passion for allergy, dermatology and specialized care, and specialized nutrition.
The Pharma Data
JANUARY 12, 2021
Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as in-vivo & in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. NEW YORK and LONDON, Jan. Dr. Graham earned an M.D.,
The Pharma Data
AUGUST 17, 2021
An experienced leader in drug development who has led and grown Lilly’s oncology business over the past several years, White will be responsible for Lilly’s launched products and Phase 3 portfolio in pain and neurodegeneration, including the potential launch of donanemab for the treatment of Alzheimer’s disease.
The Pharma Data
DECEMBER 17, 2020
Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs.
Expert insights. Personalized for you.
52 
Let's personalize your content